Calton & Associates, Inc. Bio Rad Laboratories, Inc. Transaction History

Calton & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$524.57 - $735.42 $177,304 - $248,571	-338 Closed	0 $0
Q4 2021 Jan 13, 2022	SELL	$708.84 - $794.68 $4,961 - $5,562	-7 Reduced 2.03%	338 $255,000
Q3 2021 Nov 05, 2021	SELL	$657.71 - $825.77 $1,315 - $1,651	-2 Reduced 0.58%	345 $257,000
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $6,919 - $7,788	-12 Reduced 3.34%	347 $224,000
Q1 2021 May 03, 2021	SELL	$547.01 - $662.35 $547 - $662	-1 Reduced 0.28%	359 $205,000

Q4 2020 Jan 25, 2021	BUY	$510.68 - $643.45 $183,844 - $231,642	360 New	360 $210,000

489

17.8M

44.9K

79.7K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.59B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.